Active living program for early bladder cancer patients with their own bladder
Part of Cancer, Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial tests whether a structured “active-living” program (helping you be more active in daily life) improves outcomes for people newly diagnosed with operable early bladder cancer. It may help with overall health and quality of life while you receive standard bladder cancer care without removing your bladder.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 20 years old
- Have newly diagnosed early bladder cancer that can be treated without bladder removal (keep your bladder)
- Know your diagnosis and are not planning to have cystectomy (bladder removal) right now
- Be able to talk and understand conversations with others
- Read and speak Mandarin/Chinese
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether using a patient's own tumor cells grown in a lab (organoids) can help doctors choose the best chemotherapy drugs before bladder cancer surgery. It may help find the most effective treatment for you.
This study compares two approaches for people with early-stage bladder cancer that has a low chance of coming back: either careful monitoring without immediate treatment, or receiving chemotherapy directly into the bladder to lower the risk of recurrence. It aims to see if monitoring alone is as good as chemotherapy for those with a low risk detected by a urine test.
This trial tests a new online adaptive radiotherapy technique for bladder cancer that adjusts the radiation plan daily based on changes in the bladder. It aims to improve treatment accuracy and reduce side effects.
This trial tests if using a patient's own tumor cells grown in a lab (organoids) can help choose the best chemotherapy to put directly into the bladder. It is for people with non-muscle invasive bladder cancer who need their first round of this treatment.
This trial is testing whether artificial intelligence (AI) can help surgeons perform a more precise removal of bladder tumors during a procedure called TURBT. It is for people with early-stage bladder cancer that hasn't spread into the muscle layer.
This trial tests a combination of chemotherapy and immunotherapy to treat large, non-invasive bladder cancer before and after surgery. It aims to avoid removing the bladder while still effectively treating the cancer.
Hear when a new Bladder Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.